Go Deep
Bharat Parenterals Limited
Bharat Parenterals Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 21,229 | -96.0 | 2.70 | 0.47 | 2,149.80 |
| Sep 2026 | 21,229 | -96.0 | 2.70 | 0.47 | 2,149.80 |
| Sep 2026 | 20,837 | -96.0 | 2.70 | 0.47 | 2,149.80 |
| Sep 2026 | 20,791 | -86.0 | 4.67 | 0.47 | 1,926.00 |
| Oct 2026 | 21,591 | -76.8 | 4.17 | 0.47 | 1,720.40 |
| Oct 2026 | 19,851 | -48.5 | 3.99 | 0.47 | 1,864.00 |
Bharat Parenterals Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 937,365,000.0 | 996,237,000.0 | 651,881,000.0 | 646,200,000.0 |
| Net Profit | 10,079,000.0 | -47,954,000.0 | -52,831,000.0 | -72,400,000.0 |
| EPS | 1.5 | -11.8 | -14.0 | -14.0 |
Bharat Parenterals Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 3,430,548,000.0 | 3,354,772,000.0 | 2,570,459,000.0 | 2,175,627,000.0 | — |
| Net Profit | -81,875,000.0 | -126,262,000.0 | 145,171,000.0 | 164,404,000.0 | — |
| EPS | -11.9 | -19.3 | 24.9 | 28.4 | — |
Bharat Parenterals Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 6,132,964,000.0 | 6,485,304,000.0 | 5,040,445,000.0 | 3,503,425,000.0 | — |
| Total Liabilities | 3,017,163,000.0 | 3,095,345,000.0 | 2,658,705,000.0 | 1,324,435,000.0 | — |
| Total Equity | 3,222,327,000.0 | 3,306,705,000.0 | 1,972,669,000.0 | 1,827,963,000.0 | — |
Owes vs Owns
Bharat Parenterals Limited owed ₹0.49 for every ₹1 it owned in Mar 2026, up from ₹0.38 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.49× | 0.48× | 0.53× | 0.38× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Bharat Parenterals Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 1.1%Receivables 24.6%Inventory 13.8%Fixed assets (tangible) 39.3%Intangible assets 8.7%Other assets 12.2%
How it's funded — Mar 2026
Short-term debt 4.0%Long-term debt 19.9%Payables 10.4%Other liabilities 14.9%Shareholders' equity 50.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.9 | 62.6 | 8.7 | 8.9 |
| Receivables | 150.7 | 171.7 | 141.4 | 112.4 |
| Inventory | 84.7 | 72.0 | 61.5 | 37.8 |
| Fixed assets (tangible) | 241.3 | 236.0 | 238.0 | 160.9 |
| Intangible assets | 53.6 | 53.3 | 1.0 | 0.0 |
| Long-term investments | 1.1 | 0.0 | 2.4 | 2.5 |
| Other assets | 75.0 | 53.0 | 51.0 | 27.8 |
| Liabilities & equity | ||||
| Short-term debt | 24.3 | 104.3 | 84.4 | 38.8 |
| Long-term debt | 121.8 | 75.9 | 73.2 | 10.9 |
| Payables | 63.9 | 74.2 | 59.5 | 51.3 |
| Other liabilities | 91.7 | 55.2 | 48.8 | 31.4 |
| Shareholders' equity | 311.6 | 339.0 | 238.2 | 217.9 |
| Net tangible assets | 268.6 | 277.4 | 196.2 | 182.8 |
Bharat Parenterals Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 383,623,000.0 | -272,541,000.0 | -47,056,000.0 | 216,638,000.0 | — |
| Investing Activities | 93,209,000.0 | -1,373,850,000.0 | -1,047,840,000.0 | -778,194,000.0 | — |
| Financing Activities | -470,464,000.0 | 1,563,723,000.0 | 1,104,277,000.0 | 605,979,000.0 | — |